The Materials Core (Biological Sample and Processing) is comprised ofthe Fred Hutchinson Cancer Research Center (FHCRC) and the Mayo Clinic Scottsdale. The two entities will be responsible for providing cell line and tissue reagents in support of all projects within the Center and will support the development of common reagents. Each project research plan requires well-characterized cell lines and primary tissues to further the experimental goals ofthe Center. The FHCRC portion ofthe Core will be under the direction of Dr. William Grady, who will manage the cell lines used in projects 1 through 3. The Mayo Clinic portion ofthe Core will be under the direction of Dr. Joseph Mikhaels, who will coordinate the collection and characterization of tissues. The cell lines that will be maintained and distributed to researchers are colon adenoma and adenocarcinoma and Barrett's Esophagus and esophageal adenocarcinoma cell lines. Primary tissue samples will be collected during endoscopy and colonoscopy following procedures approved by the Institutional Review Board at Mayo Clinic.

Public Health Relevance

This Core will provide experimental samples for all experiments designed and completed within the other projects of the Center. The projects will contribute to the overall understanding of cancer, which would not be possible without this Core. By providing samples of cancer for experimentation, the Core is directly and positively impacting progress made in cancer research.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-SRLB-9 (O1))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Arizona State University-Tempe Campus
United States
Zip Code
Shiovitz, Stacey; Bertagnolli, Monica M; Renfro, Lindsay A et al. (2014) CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer. Gastroenterology 147:637-45
Yu, M; Trobridge, P; Wang, Y et al. (2014) Inactivation of TGF-* signaling and loss of PTEN cooperate to induce colon cancer in vivo. Oncogene 33:1538-47
Luo, Yanxin; Wong, Chao-Jen; Kaz, Andrew M et al. (2014) Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology 147:418-29.e8
Kaz, Andrew M; Grady, William M (2014) Epigenetic biomarkers in esophageal cancer. Cancer Lett 342:193-9
Codomo, Christine A; Furuyama, Takehito; Henikoff, Steven (2014) CENP-A octamers do not confer a reduction in nucleosome height by AFM. Nat Struct Mol Biol 21:4-5
Yang, Fan; Teves, Sheila S; Kemp, Christopher J et al. (2014) Doxorubicin, DNA torsion, and chromatin dynamics. Biochim Biophys Acta 1845:84-9
Zentner, Gabriel E; Henikoff, Steven (2014) High-resolution digital profiling of the epigenome. Nat Rev Genet 15:814-27
Swygert, Sarah G; Manning, Benjamin J; Senapati, Subhadip et al. (2014) Solution-state conformation and stoichiometry of yeast Sir3 heterochromatin fibres. Nat Commun 5:4751
Grady, William M; Pritchard, Colin C (2014) Molecular alterations and biomarkers in colorectal cancer. Toxicol Pathol 42:124-39
Khatayevich, Dmitriy; Page, Tamon; Gresswell, Carolyn et al. (2014) Selective detection of target proteins by peptide-enabled graphene biosensor. Small 10:1505-13, 1504

Showing the most recent 10 out of 22 publications